Pfizer Inc.
ANTIBODIES SPECIFIC FOR GUCY2C AND USES THEREOF
Last updated:
Abstract:
The present invention provides novel antibodies that specifically bind to GUCY2c and uses thereof in the treatment of cancer. The present invention further provides novel bispecific antibodies comprising such antibodies and uses thereof in the treatment of cancer.
Status:
Application
Type:
Utility
Filling date:
21 May 2019
Issue date:
9 Jan 2020